Saturday, June 25, 2022
HomeAsian NewsMGI Unleashes The Energy Of Precision Medication

MGI Unleashes The Energy Of Precision Medication



AsianScientist (Might 24, 2022)–All through historical past, healthcare has been pushed by one overarching objective: to develop therapies which can be extra correct and efficient for everybody. In at present’s world, the mix of superior genetic sequencing, big-data analytics and quick supercomputing helps healthcare professionals refine and individualize therapies. Often known as “precision (or personalised) medication”, this superior know-how delivers a extremely particular therapy suited to each particular person affected person.

Healthcare professionals now know that the genetics of an individual and its interplay with the surroundings is chargeable for nearly all of the illnesses and well being problems. Subsequently, counting on a one-approach-fits-all mentality may very well be counter-productive in offering actually efficient therapy to individuals. That’s the place precision medication is available in. At its core, precision medication acknowledges that whereas two individuals may share the identical illness, one may reply to a specific therapy in a different way than the opposite based mostly on their genetic and organic make-up. On the forefront of this know-how is MGI, a Shenzhen-based firm dedicated to constructing life-science instruments by means of clever innovation.

With the newest sequencing know-how* and state-of-the-art automation merchandise, MGI seems to be to harness the huge pool of genetic info to advance precision medication, empowering the healthcare business to make better-informed choices that increase affected person outcomes.

&nbsp>
Unlocking the potential of human genomics

With the fixed innovation in sequencing applied sciences, the method of decoding a single genome, which value over US$3.8 billion 22 years in the past and took 13 years to finish, can now be performed in only a day for under US$500. At this time’s next-generation applied sciences afford the simultaneous sequencing of a number of genes at an unmatched pace and accuracy, serving to healthcare professionals present the suitable therapy to sufferers on the proper time.

Taking a look at the advantages precision medication brings, many nations corresponding to the USA, Singapore, France, and the United Arab Emirates have launched nationwide endeavors to map the genomes of their residents. MGI’s inhabitants scale sequencing know-how* has been leveraged efficiently in a number of nationwide genome applications world wide to assist the governments’ goal to pioneer a medical system for predictive, preventive, and personalised therapy.

Moreover, MGI’s involvement has been essential to the progress of the “Million Microbiome of People Undertaking”, launched in 2019 on the 14th Worldwide Convention on Genomics, which happened in Shenzhen. The mission gathers scientists from all around the world to sequence and analyze a million intestinal, oral, pores and skin, and reproductive-tract samples, with MGI’s sequencing platform* supporting the worldwide scientific endeavor. The mission intends to construct the biggest human microbiome database ever, which is able to present very important insights into formulating improved diagnostic and therapy strategies for precision medication.

&nbsp>
Advancing precision medication in oncology and past

Being one of many few firms on the earth, which have the power to independently develop and mass-produce scientific high-throughput gene sequencers, MGI has empowered the worldwide precision-medicine business for a few years with its key sequencing applied sciences*. Specifically, because of the effectivity of MGI’s sequencing machines corresponding to DNBSEQ-G400 and DNBSEQ-T7 high-throughput sequencers*, Beijing-based GrandOmics, an organization specializing in third-generation sequencing, was capable of broaden its product portfolio in sequencing companies and precision medication.

In one other instance, MGI’s array of extremely correct, cost-effective, and versatile sequencing know-how* was essential in enhancing the cardiovascular testing companies of Anngeen Applied sciences, a biotechnology firm based mostly in Beijing that makes use of gene sequencing for scientific prognosis. Moreover, MGI’s units have additionally been central to the combat towards infectious illnesses corresponding to COVID-19, the place affected person samples need to be examined as shortly and as precisely as potential to curb the unfold of the virus.

Other than its sequencing know-how*, MGI’s fleet of automation methods and robotic ultrasound merchandise are additionally making waves within the precision-medicine business. Pushed by the necessity for large-scale testing, MGI’s laboratory automation system ensures that genome sequencing runs as seamlessly as potential to generate outcomes quickly.

Relating to saving lives, time is usually a essential issue. Sufferers staying distant from metropolis facilities the place main healthcare establishments are sometimes positioned may gain advantage from MGI’s robotic ultrasound units that present distant well being screening. Other than saving journey time and enhancing accessibility to diagnostic assets, MGI’s ultrasonic screening units additionally rework the telemedicine expertise. Whereas typical telemedicine session strategies are restricted to audio and visible interactions, physicians utilizing MGI’s revolutionary gadget may harness the properties of ultrasonic waves to look at sufferers much more precisely. With its newest ultrasound-based know-how*, MGI performs a pivotal position in selling most cancers prevention and early therapy, which may vastly enhance the prognosis of sufferers.

&nbsp>
Dedication to innovation and collaboration

Geared up with a complete suite of gene applied sciences and merchandise, MGI is dedicated to advancing precision medication on all fronts by means of innovation and collaboration. In an effort to deliver a simplified and easy-to-operate sequencing workflow to market, MGI has not too long ago partnered with Singapore-based Nalagenetics, a biotechnology firm specializing in inexpensive personalised screening and intervention. Working collectively, each firms share the identical objective of decreasing the technical information and monetary necessities of native healthcare establishments to quick undertake cutting-edge know-how.

Collaborating extensively with all stakeholders inside the healthcare ecosystem, MGI continues to innovate on the forefront of gene sequencing to interrupt down the technical limitations of earlier applied sciences, whereas accelerating the event of precision medication to profit numerous members of our societies.

Within the PrecisionMed Exhibition Dubai 2022 (Might 24-25), MGI shares tips on how to unleash the facility of precision medication with life science applied sciences into human well being.

To study extra about it, please click on right here.

*Except in any other case knowledgeable, StandardMPS and CoolMPS sequencing reagents, and sequencers to be used with such reagents aren’t out there in Germany, USA, Spain, UK, Hong Kong, Sweden, Belgium, Italy, Finland, Czech Republic, Switzerland, Portugal and Austria. HotMPS sequencing reagent and sequencers to be used with such reagents are solely out there in chosen nations.

———

Disclaimer: This text doesn’t essentially replicate the views of AsianScientist or its workers.



RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments